AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW

Posted on by Phil Franchina

APDA remains steadfast in its mission to support those impacted by Parkinson’s disease as new law provides hope for...see more accelerated progress toward a cure NEW YORK, NY, JULY 3, 2024 – The American Parkinson Disease Association (APDA) is celebrating the President’s signing of the National Plan to End Parkinson’s Act yesterday, marking the enactment of […]

Read More

Historic News for the PD Community

Posted on by Phil Franchina

The National Plan to End Parkinson’s Act Has Been Signed into Law Today we celebratethe President’s signing of the...see more National Plan to End Parkinson’s Act, marking the enactment of the first-ever federal legislation dedicated to curing and preventing Parkinson’s disease (PD) and ensuring quality care for those impacted by this chronic and progressive neurologic disease. […]

Read More

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

Posted on by Phil Franchina

APDA is Committed to Reaching & Supporting More People with Parkinson’s Disease NEW YORK, NY, JUNE 24, 2024 –...see more The mission of the American Parkinson Disease Association (APDA) is to provide the support, education, and research to help everyone impacted by Parkinson’s disease (PD) live life to the fullest. To promote health equality and access […]

Read More

Understanding levodopa-induced dyskinesias: APDA-funded research published 

Posted on by Phil Franchina

Congratulations to our 2020 APDA Research Grant Awardee Dr. Karen Jaunarajs for her work on understanding levodopa induced dyskinesias....see more Her study was recently published in Journal of Neuroscience. Dr. Jaunarajs works closely with Dr. David Standaert, Chairman of APDA’s Scientific Advisory Board, and the Chairman of University of Alabama at Birmingham’s Department of Neurology, which […]

Read More

How alpha-synuclein affects brain cell communication: APDA-funded research published

Posted on by Phil Franchina

In a recently published study, Dr. Gary Ho, a recipient of APDA’s most prestigious George C. Cotzias grant, studied...see more the role of alpha-synuclein in the formation and recycling of synaptic vesicles, the system that allows nerves to talk to each other. Abnormally aggregated alpha-synuclein is a main component of the Lewy body which is the […]

Read More

A Tribute to Dr. Mahlon DeLong

Posted on by Phil Franchina

Parkinson’s pioneer and friend Dr. Mahlon DeLong was a pioneer in the Parkinson’s disease (PD) field and a dear...see more friend and longtime partner of the American Parkinson Disease Association (APDA). He sadly passed away on May 17, 2024. In tribute to Dr. DeLong, we reflect on the remarkable life and career of a man who […]

Read More

The Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act has passed through both Houses of Congress!

Posted on by Phil Franchina

Breaking news! This week, the Senate passed the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s...see more Act! Now that the bill has passed through both houses of Congress, it heads to the President’s desk where it will be signed into law!  Here is some history about the National Plan: In 2022, the […]

Read More